A detailed history of Wedge Capital Management L L P transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Wedge Capital Management L L P holds 43,503 shares of COLL stock, worth $1.32 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
43,503
Previous 46,205 5.85%
Holding current value
$1.32 Million
Previous $1.49 Million 12.98%
% of portfolio
0.03%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$31.4 - $39.07 $84,842 - $105,567
-2,702 Reduced 5.85%
43,503 $1.68 Million
Q2 2024

Jul 17, 2024

BUY
$31.36 - $39.99 $96,871 - $123,529
3,089 Added 7.16%
46,205 $1.49 Million
Q1 2024

Apr 23, 2024

BUY
$31.23 - $40.91 $465,327 - $609,559
14,900 Added 52.81%
43,116 $1.67 Million
Q3 2023

Oct 13, 2023

BUY
$21.23 - $24.28 $599,025 - $685,084
28,216 New
28,216 $630,000

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.04B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Wedge Capital Management L L P Portfolio

Follow Wedge Capital Management L L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

News

Stay updated on Wedge Capital Management L L P with notifications on news.